DK0804166T3
Controlled release formulation (albuterol)
3 sheets
Sheet 1 Sheet 2 Sheet 3
81 members in 16 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 55300895 | United States of America | A | |
| 55300895 | United States of America | A | |
| 9617991 | United States of America | W | |
| 9617991 | United States of America | W | |
| 553008 | – | – | – |
| US19950553008 | – | – | – |
| US1996017991 | – | – | – |
| WO1996US17991 | – | – | – |
Members81
| Document | Office | Kind | |
|---|---|---|---|
| IL110744D0 | Israel | D0 | |
| CA2131647A1 | Canada | A1 | |
| EP0642785A2 | European Patent Office (EPO) | A2 | |
| ES2070810T1 | Spain | T1 | |
| JPH07165615A | Japan | A | |
| GR950300035T1 | Greece | T1 | |
| DE642785T1 | Germany | T1 | |
| US5455046A | United States of America | A | |
| US5512297A | United States of America | A | |
| US5554387A | United States of America | A | |
| EP0642785A3 | European Patent Office (EPO) | A3 | |
| CA2208230A1 | Canada | A1 | |
| WO9716172A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7725396A | Australia | A | |
| US5662933A | United States of America | A | |
| US5667801A | United States of America | A | |
| CA2251816A1 | Canada | A1 | |
| CA2461157A1 | Canada | A1 | |
| WO9739050A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0804166A1 | European Patent Office (EPO) | A1 | |
| AU2680597A | Australia | A | |
| MX9704910A | Mexico | A | |
| US5773025A | United States of America | A | |
| JPH10507210A | Japan | A | |
| US5846563A | United States of America | A | |
| IL110744A | Israel | A | |
| EP0912627A1 | European Patent Office (EPO) | A1 | |
| JPH11507958A | Japan | A | |
| CA2131647C | Canada | C | |
| IL126595D0 | Israel | D0 | |
| US5958456A | United States of America | A | |
| KR20000005554A | Republic of Korea | A | |
| KR20000018064A | Republic of Korea | A | |
| US6048548A | United States of America | A | |
| KR100264024B1 | Republic of Korea | B1 | |
| US6136343A | United States of America | A | |
| NZ332299A | New Zealand | A | |
| EP1101489A2 | European Patent Office (EPO) | A2 | |
| US6245356B1 | United States of America | B1 | |
| EP1101489A3 | European Patent Office (EPO) | A3 | |
| AU739114B2 | Australia | B2 | |
| EP0642785B1 | European Patent Office (EPO) | B1 | |
| AT207742T | Austria | T | |
| ATE207742T1 | Austria | T1 | |
| US2001046516A1 | United States of America | A1 | |
| DE69428853D1 | Germany | D1 | |
| ES2070810T3 | Spain | T3 | |
| IL126595A | Israel | A | |
| CA2208230C | Canada | C | |
| DK0642785T3 | Denmark | T3 | |
| JP3250737B2 | Japan | B2 | |
| PT642785E | Portugal | E | |
| DE69428853T2 | Germany | T2 | |
| IL143642D0 | Israel | D0 | |
| NZ508467A | New Zealand | A | |
| KR100384215B1 | Republic of Korea | B1 | |
| US6709677B2 | United States of America | B2 | |
| US6726930B1 | United States of America | B1 | |
| CA2251816C | Canada | C | |
| US2004234598A1 | United States of America | A1 | |
| US2004241233A1 | United States of America | A1 | |
| EP0804166A4 | European Patent Office (EPO) | A4 | |
| EP1101489B1 | European Patent Office (EPO) | B1 | |
| AT318586T | Austria | T | |
| ATE318586T1 | Austria | T1 | |
| EP0912627A4 | European Patent Office (EPO) | A4 | |
| DE69434640D1 | Germany | D1 | |
| US2006105035A1 | United States of America | A1 | |
| PT1101489E | Portugal | E | |
| ES2254274T3 | Spain | T3 | |
| DE69434640T2 | Germany | T2 | |
| CA2461157C | Canada | C | |
| JP4077886B2 | Japan | B2 | |
| EP2286796A2 | European Patent Office (EPO) | A2 | |
| EP0804166B1 | European Patent Office (EPO) | B1 | |
| AT507820T | Austria | T | |
| ATE507820T1 | Austria | T1 | |
| DE69638364D1 | Germany | D1 | |
| DK0804166T3This record | Denmark | T3 | |
| ES2366278T3 | Spain | T3 | |
| EP2286796A3 | European Patent Office (EPO) | A3 |
Numbers
- Publication
- 0804166
- Publication, DOCDB
- 0804166
- Publication, EPODOC
- DK0804166T
- Application
- 969403526
- Application, DOCDB
- 96940352
- Application, EPODOC
- DK19960940352T
Titles2
- Danish
- Formulering med kontrolleret frigivelse (Albuterol)
- English
- Controlled-release formulation (Albuterol)
Classification
- CPC, 9
- A61K31/137
- A61K9/20
- A61K9/2009
- A61K9/2018
- A61K9/205
- A61K9/2054
- A61K9/2866
- C08J3/075
- A61P11/08
- IPC, 10
- A61K9 14
- A61K9 20
- A61K9 22
- A61K9 28
- A61K9 30
- A61K31 137
- A61K31 40
- A61K31 44
- A61K47 36
- C08J3 075
